Cell stem cellNeurosciencePeer-reviewed journal article
A reference induced pluripotent stem cell line for large-scale collaborative studies
Caroline B. PantazisiD, Andrian YangiD, Erika Lara, Justin A. McDonoughiD, Cornelis BlauwendraatiD, Lirong PengiD, Hideyuki OguroiD, Jitendra Kumar KanaujiyaiD, Jizhong ZouiD, David P. Sebesta, Gretchen Pratt, Erin CrossiD, Jeffrey Blockwick, Philip Buxton, Lauren Kinner-Bibeau, Constance Medura, Christopher Tompkins, Stephen H. HughesiD, Marianita SantianaiD, Faraz FaghriiD, Mike A. NallsiD, Dan VitaleiD, Shannon L. Ballard, Yue Andy QiiD, Daniel M. RamosiD, , Florian T. MerkleiD
- Citations
- 323
- FWCI
- 18.20
- Field percentile
- top 1%
Abstract
Human induced pluripotent stem cell (iPSC) lines are a powerful tool for studying development and disease, but the considerable phenotypic variation between lines makes it challenging to replicate key findings and integrate data across research groups. To address this issue, we sub-cloned candidate iPSC lines and deeply characterised their genetic properties using whole genome sequencing, their genomic stability upon CRISPR/Cas9-based gene editing, and their phenotypic properties including differentiation to commonly-used cell types. These studies identified KOLF2.1J as an all-around well-performing iPSC line. We then shared KOLF2.1J with groups around the world who tested its performance in head-to-head comparisons with their own preferred iPSC lines across a diverse range of differentiation protocols and functional assays. On the strength of these findings, we have made KOLF2.1J and hundreds of its gene-edited derivative clones readily accessible to promote the standardization required for large-scale collaborative science in the stem cell field. SummaryThe authors of this collaborative study deeply characterized human induced pluripotent stem cell (iPSC) lines to rationally select a clonally-derived cell line that performs well across multiple modalities. KOLF2.1J was identified as a candidate reference cell line based on single-cell analysis of its gene expression in the pluripotent state, whole genome sequencing, genomic stability after highly efficient CRISPR-mediated gene editing, integrity of the p53 pathway, and the efficiency with which it differentiated into multiple target cell populations. Since it is deeply characterized and can be readily acquired, KOLF2.1J is an attractive reference cell line for groups working with iPSCs. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/472643v6_ufig1.gif" ALT="Figure 1"> View larger version (84K): org.highwire.dtl.DTLVardef@cef106org.highwire.dtl.DTLVardef@31d5d8org.highwire.dtl.DTLVardef@1ce6d8corg.highwire.dtl.DTLVardef@17a19d2_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: whole-genome sequencing
- research focus: cell type annotation
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The complete genome of the KOLF2.1J reference iPSC line
Pilar Álvarez Jerez, Arang Rhie, … Cornelis Blauwendraat·bioRxiv·Mar 12, 2026
- A new NHGRI Sample Repository for Human Genetic Research collection of induced pluripotent stem cell lines.
Tatyana Pozner, Christine Grandizio, … Laura Scheinfeldt·bioRxiv·Aug 5, 2025
- High density SNP array and reanalysis of genome sequencing uncovers CNVs associated with neurodevelopmental disorders in KOLF2.1J iPSCs
Carolina Gracia-Diaz, Jonathan Elliot Perdomo, … Naiara Akizu·bioRxiv·Jun 26, 2023
- Common genetic variation drives molecular heterogeneity in human iPSCs
Helena Kilpinen, Angela Goncalves, … Daniel J Gaffney·bioRxiv·May 25, 2016
- The Genetic Discovery (GeDi) resource: Deep characterization of a multi-ancestry panel of human reference iPSCs for functional genomic studies
Adrian Melo-Carrillo, Enrica Pellegrino, … William C. Skarnes·bioRxiv·Oct 16, 2026
- Development of an efficient single-cell cloning and expansion strategy for genome edited induced pluripotent stem cells
N. Bhargava, P. Thakur, … S. Ramalingam·Molecular Biology ReportsPeer-reviewed·May 30, 2022